Todd Schonherz, CEO, AON, CanCare Board of Directors; Stephen "Fred" Divers, MD, Chief Medical Officer, AON, Medical Oncologist, Genesis Cancer and Blood Institute; Michael J. Castine, III, MD, Medical Oncologist, Hematology Oncology Clinic; Jose Alemar, MD, Medical Oncologist, Florida Oncology and Hematology; Luis T. Campos, MD, President & Medical Oncologist, Oncology Consultants; Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC, VP, Clinical Innovation, AON; Anne Marie F. Rainey, MSN, RN, CHC, CPHQ, FACCC, Director, Quality and Value-Based Care, AON; Isabel Verastegul, AON Care Coordination Manager, CanCare Survivor Volunteer; Darcie Wells, President and Chief Executive Officer, CanCare
Todd Schonherz, CEO, AON, CanCare Board of Directors; Stephen "Fred" Divers, MD, Chief Medical Officer, AON, Medical Oncologist, Genesis Cancer and Blood Institute; Michael J. Castine, III, MD, Medical Oncologist, Hematology Oncology Clinic; Jose Alemar, MD, Medical Oncologist, Florida Oncology and Hematology; Luis T. Campos, MD, President & Medical Oncologist, Oncology Consultants; Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC, VP, Clinical Innovation, AON; Anne Marie F. Rainey, MSN, RN, CHC, CPHQ, FACCC, Director, Quality and Value-Based Care, AON; Isabel Verastegul, AON Care Coordination Manager, CanCare Survivor Volunteer; Darcie Wells, President and Chief Executive Officer, CanCare